Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial". Bleeding Thromb Vascul Biol [Internet]. 2025 Apr. 16 [cited 2025 Jun. 6];4(2). Available from: https://www.btvb.org/btvb/article/view/179